OBJECTIVE： To provide reference for reasonably designing package inserts of ointment for manufacturers. METHODS： According to items included in Management Regulation for Package Insert and Label and Specification for Chemicals and Biological Products for Treatment， labeled items in package inserts of 51 kinds of ointment for external use during Jan.-Jun. 2016 in our hospital were analyzed. RESULTS： Among the 51 kinds of ointment， 39 were domestic varieties and 12 were imported varieties. In the package inserts of 39 domestic varieties， items with lower labeling rates were overdose， pharmacokinetics， use guidance， pharmacology and toxicology， with labeling rates of 2.6％， 5.1％， 15.4％， 28.2％； while the labeling rates of imported varieties were 16.7％， 83.3％， 75.0％， 100％. Compared with package inserts of imported ointment， composition， dosage and usage， adverse reactions， contraindications， precautions， drug interactions， medication for special populations were not enough detailed in domestic ointments. CONCLUSIONS： It is suggested that manufacturers consult medicine experts， list all auxiliary materials through Management Regulation for Drug Description and Label， refine and improve the labeling contents of dosage and usage， adverse reactions， precautions， medication for special populations， pharmacology and toxicology， overdose， etc. In addition， administrative departments should strengthen the regulatory approval efforts.